AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
YOKOHAMA, JAPAN -- Two of the longest studies of maintenance therapy for bipolar disorder found that both lithium and the antiepileptic drug lamotrigine delayed relapse, with lithium predominantly preventing manic episodes and lamotrigine predominantly preventing depression, Dr. Joseph R. Calabrese reported at the 12th World Congress of Psychiatry.
Two international, open-label studies treated 1,315 symptomatic bipolar patients with lamotrigine and concurrent psychotropics. The 638 patients stabilized in 8-16 weeks of treatment then were randomized in a double-blind fashion to maintenance therapy with lithium, lamotrigine, or placebo for 18 months (76 weeks), with…